ATE89860T1 - Attenuierte viren. - Google Patents

Attenuierte viren.

Info

Publication number
ATE89860T1
ATE89860T1 AT90300500T AT90300500T ATE89860T1 AT E89860 T1 ATE89860 T1 AT E89860T1 AT 90300500 T AT90300500 T AT 90300500T AT 90300500 T AT90300500 T AT 90300500T AT E89860 T1 ATE89860 T1 AT E89860T1
Authority
AT
Austria
Prior art keywords
poliovirus
type
positions
attenuated
attached viruses
Prior art date
Application number
AT90300500T
Other languages
English (en)
Inventor
Jeffrey William Almond
Philip David Minor
Michael Anthony Skinner
Of Molecular Biolog Laboratory
Colin Young
Texas Veterinary Parasitology
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Application granted granted Critical
Publication of ATE89860T1 publication Critical patent/ATE89860T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32361—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Gas Separation By Absorption (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90300500T 1989-01-18 1990-01-18 Attenuierte viren. ATE89860T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898901094A GB8901094D0 (en) 1989-01-18 1989-01-18 Attenuated viruses

Publications (1)

Publication Number Publication Date
ATE89860T1 true ATE89860T1 (de) 1993-06-15

Family

ID=10650230

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90300500T ATE89860T1 (de) 1989-01-18 1990-01-18 Attenuierte viren.

Country Status (12)

Country Link
EP (1) EP0383433B1 (de)
JP (1) JPH04502705A (de)
AT (1) ATE89860T1 (de)
AU (1) AU649376B2 (de)
CA (1) CA2045649C (de)
DE (1) DE69001689T2 (de)
DK (1) DK0383433T3 (de)
ES (1) ES2058777T3 (de)
GB (2) GB8901094D0 (de)
NZ (1) NZ232152A (de)
WO (1) WO1990008189A1 (de)
ZA (1) ZA90324B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286640A (en) * 1988-01-05 1994-02-15 Almond Jeffrey W Attenuated polioviruses
GB8901093D0 (en) * 1989-01-18 1989-03-15 Almond Jeffrey W Attenuated viruses
DE68925356T2 (de) * 1989-06-08 1996-09-05 American Cyanamid Co Nicht-zurückmutierende RNA-Viren
GB9107552D0 (en) * 1991-04-10 1991-05-29 Macadam Andrew J Attenuated viruses
GB9107563D0 (en) * 1991-04-10 1991-05-29 Macadam Andrew J Thermostable viruses
GB9323819D0 (en) * 1993-11-19 1994-01-05 Smithkline Beecham Biolog Anlytical method
GB0615933D0 (en) 2006-08-10 2006-09-20 Nat Inst Biological Standards & Control Attenuated polioviruses
GB201022077D0 (en) 2010-12-29 2011-02-02 Health Prot Agency Inactivated poliovaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8800100D0 (en) * 1988-01-05 1988-02-10 Almond J W Attenuated viruses
GB8901093D0 (en) * 1989-01-18 1989-03-15 Almond Jeffrey W Attenuated viruses

Also Published As

Publication number Publication date
ES2058777T3 (es) 1994-11-01
GB8901094D0 (en) 1989-03-15
WO1990008189A1 (en) 1990-07-26
CA2045649C (en) 1998-11-10
NZ232152A (en) 1992-11-25
AU649376B2 (en) 1994-05-19
CA2045649A1 (en) 1990-07-19
DK0383433T3 (da) 1993-06-21
EP0383433A1 (de) 1990-08-22
JPH04502705A (ja) 1992-05-21
EP0383433B1 (de) 1993-05-26
DE69001689T2 (de) 1993-09-02
GB2228741B (en) 1992-07-22
AU4947990A (en) 1990-08-13
GB2228741A (en) 1990-09-05
ZA90324B (en) 1990-10-31
DE69001689D1 (de) 1993-07-01
GB9001111D0 (en) 1990-03-21

Similar Documents

Publication Publication Date Title
DE59206730D1 (de) Virales Agens assoziiert mit der Mystery Swine Disease
DK0386734T3 (da) Immunogene regioner på E-7-proteinet af humant papillomavirus type 16
DK0429381T3 (da) Landbrugsmaskine med forbedret ophængningsanordning for gruppen af arbejdsorganer
ATE89860T1 (de) Attenuierte viren.
FI882689A0 (fi) Hundens coronavirusvaccin.
DE68908190D1 (de) Attenuierte viren.
ATE86660T1 (de) Attenuierte viren.
ATE276761T1 (de) Vorbeugung von typ-1 diabetes und anderen nicht- polio enteroviren
FI890116A0 (fi) Icke-reverterande rna-virus.
PT1149901E (pt) Mutantes de pestivirus e vacinas contendo os mesmos
ATE132527T1 (de) Nicht-zurückmutierende rna-viren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee